Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AZD9496 is an orally available selective estrogen receptor(ERα) antagonist, with potential antineoplastic activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 51.00 | |
2 mg | In stock | $ 71.00 | |
5 mg | In stock | $ 118.00 | |
10 mg | In stock | $ 198.00 | |
25 mg | In stock | $ 370.00 | |
50 mg | In stock | $ 548.00 | |
100 mg | In stock | $ 792.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 113.00 |
Description | AZD9496 is an orally available selective estrogen receptor(ERα) antagonist, with potential antineoplastic activity. |
Targets&IC50 | ERα:0.28 nM. |
In vitro | AZD9496 showed pmol/L equipotent binding to both ERα and ERβ isoforms. AZD9496 directly targets ERα for downregulation in vitro. And it also antagonizes and downregulates mutant ER in vitro and in vivo. The IC50s of ERα binding, ERα downregulation, ERα antagonism for AZD9496 are 0.82, 0.14 and 0.28 nM, respectively[1]. |
In vivo | AZD9496 showed high oral bioavailability across three species (F% 63, 91, and 74, rat, mouse, and dog, respectively) with generally low volume and clearance across species, albeit a higher clearance in mouse. The percent free levels in human plasma of 0.15% were 5-fold higher than those measured for fulvestrant. AZD9496 is a potent, oral inhibitor of breast tumor growth in vivo. AZD9496 causes tumor regressions in combination with PI3K pathway and CDK4/6 inhibitors and in an estrogen-deprived ER+ model of resistance. This effect was accompanied by a dose-dependent decrease in PR protein levels. AZD9496 is currently being evaluated in a phase I Clinicalal trial[1]. |
Cell Research | Cells were grown in steroid-free conditions in SILAC media containing 13C615N4 L-arginine to label ERα peptide as "heavy" and then switched to grow in media containing unlabeled l-arginine to label newly synthesized protein as "normal" with 0.1% DMSO, 300 nmol/L tamoxifen, 100 nmol/L AZD9496, or 100 nmol/L fulvestrant for the time indicated. (Only for Reference) |
Molecular Weight | 442.47 |
Formula | C25H25F3N2O2 |
CAS No. | 1639042-08-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 82 mg/mL (185.3 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: 82 mg/mL (185.3 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AZD9496 1639042-08-2 Endocrinology/Hormones Estrogen/progestogen Receptor Estrogen Receptor/ERR AZD 9496 AZD-9496 inhibit Inhibitor inhibitor